Proscia will be in London, UK for the 9th Digital Pathology and AI Congress 7-8 December 2022, where the focus of this year’s event is utilizing AI & digital pathology to advance pathology practice, enable enhanced patient care and further drug discovery.
Visit us at Booth #1 for live product demos where you can see first-hand how we support diagnostic labs and life sciences teams with Concentriq®, our AI-ready software platform powering the modern pathology lab. Meet with our experts and take the next step on your digital and computational pathology journey.
Computational Pathology and AI Session
Real-world learnings from the deployment of digital and computational pathology at scale: The Unilabs Story
Unilabs is one of Europe’s leading diagnostics companies, offering a complete range of laboratory, pathology and imaging services to patients across four continents. Join Dr. Rahul Chaudhary and Dr. Thomas Sollie as they relate their first-hand experiences as pathologists deploying and integrating AI into diagnostic processes. Dr. Chaudhary will share the Unilabs story, and their vision of becoming the most digitally-driven diagnostic group. Dr. Sollie will then share the results of the recent study on the potential impact of Proscia’s DermAI on the laboratory’s high-throughput pathology operations and decreased turnaround times that could enable patients to start treatment sooner.
Day 2, Thursday, December 8th | 12:55–1:25 PM BST
Contributing Authors: Julianna Ianni, Sean Grullon, Vaughn Spurrier, Yang Jiang, Jiayi Zhao
Scientific Poster Presentation
Using AI to Understand the Sources of Diagnostic Discordance in Melanocytic Lesions
The digitization of pathology workflows has opened up the potential for enormous benefit from the use of AI to drive diagnostic assistance and workflow optimization. AI models, however, rely not only on high quality images, but also on high quality labels. In many diagnostic domains, there is a high discordance rate among pathologists resulting in uncertain labels with which to build AI models. This study uses an AI model of benign vs suspected malignant melanocytic lesions to disentangle inter-pathologist discordance into its two distinct components of bias and noise, and explore the unique impact of each on AI model development.
Poster Space #15T
We’ve curated the resources below for you and your team to learn more about Proscia, our products and solutions.
Brochures & White Papers
News, Articles & Blogs
Proscia’s Concentriq Dx Attains CE Mark Under IVDR for Use in Primary Diagnosis
Uppsala University Hospital Selects Proscia to Deliver Full-Scale Digital Pathology Adoption
LabPON Adopts Proscia’s Concentriq to Meet Demand for Diagnostic Services Amid Rising Cancer Burden
Proscia and Unilabs Enter Strategic Partnership to Advance the Use of Artificial Intelligence in High-Throughput Diagnostic Workflows
Proscia and Visiopharm Partner to Deliver AI-Powered Pathology to Drive Insight in Cancer Diagnosis
Proscia Raises $37M Series C to Fulfill the Promise of Precision Medicine With AI-Enabled Pathology
Proscia and Siemens Healthineers Ink Agreement to Expand Global Reach of Digital Pathology
Tailored for Real-World: A Whole Slide Image Classification System Validated on Uncurated Multi-Site Data Emulating the Prospective Pathology Workload
Proscia Announces Artificial Intelligence Breakthrough in Melanoma Detection
Virtual Events & Webinars
Watch a panel discussion and Q&A with Proscia and thought leaders from our customers LabPON and Unilabs, along with AI partners Visiopharm and Ibex Medical Analytics. The focus of this pre-ECP discussion is on market trends among early adopters of AI in the European market, real-world experiences integrating AI within the digital pathology workflow and key decision-making considerations for successful implementations.
Hear from our customer LabPON as they share insights and key results from testing the interoperability of Proscia’s Concentriq® Dx digital pathology software platform and the IBEX GalenTM Platform.
This virtual event brings together researchers, scientists and digital pathology pioneers to accelerate life sciences research; includes a keynote with Dr. Scott Gottlieb, former FDA Commissioner, and breakout sessions with Bristol Myers Squibb, Charles River Labs, Google and Visiopharm.
Take The Next Step
If you'd like to learn more about Proscia's digital and computational pathology solutions, contact us or register for a demo of Concentriq.